Epidemico is a health informatics company driving the next generation of public health. Our solutions include sophisticated surveillance systems and consumercentric engagement capabilities. We utilize natural language processing, crowdsourcing, social networking, and public health expertise to provide real-time insights on population health. Our HealthWatcher solution is utilized by Life Science Companies to identify, aggregate, classify and visualize digital conversations for drugs, devices and vaccines. It enables clients to quickly gain a comprehensive understanding of patient-product interactions in the context of adverse drug reactions, consumer sentiment, health outcomes, product benefits, adherence and more. Our work is endorsed and co-branded by several government entities (e.g. CDC, FDA, HSS) and nationally recognized by the Smithsonian and the Library of Congress as well as media such as the New York Times, NBC, and CNN. Epidemico is a spin-off company from Boston Children’s Hospital, Harvard Medical School, and MIT; headquartered in Boston, Massachusetts. As of 2014, Epidemico is a wholly-owned subsidiary of Booz Allen Hamilton.